@article{894e56f6134c4a61ad39a222b7b7dadc,
title = "Jadomycins inhibit type II topoisomerases and promote DNA damage and apoptosis in multidrug-resistant triple-negative breast cancer cells",
author = "Hall, {Steven R.} and Jay Toulany and Bennett, {Leah G.} and Martinez-Farina, {Camilo F.} and Robertson, {Andrew W.} and Jakeman, {David L.} and Goralski, {Kerry B.}",
note = "Funding Information: K.B.G. received research infrastructure funding from the Canadian Foundation for Innovation Leaders Opportunity Fund. The research was supported by operating grants from the Canadian Breast Cancer Foundation— Atlantic Chapter, the Dalhousie Pharmacy Endowment, the Beatrice Hunter Cancer Research Institute, and the Dalhousie University Faculty of Health Professions to K.B.G.; and from the Nova Scotia Health Research Foundation, the Natural Sciences and Engineering Research Council, and the Canadian Institutes of Health Research to D.L.J. S.R.H. was supported by a Nova Scotia Health Research Foundation Scotia Scholar Award and a Level 2 Izaak Walton Killam Predoctoral Scholarship. Publisher Copyright: Copyright {\textcopyright} 2017 by The American Society for Pharmacology and Experimental Therapeutics.",
year = "2017",
month = nov,
doi = "10.1124/jpet.117.241125",
language = "English",
volume = "363",
pages = "196--210",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",
}
